Trends of Colorectal Cancer Prevalence in Kazakhstan Related to Screening.

Colonoscopy Colorectal cancer Hemoccult test Kazakhstan Screening

Journal

Clinical endoscopy
ISSN: 2234-2400
Titre abrégé: Clin Endosc
Pays: Korea (South)
ID NLM: 101576886

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 12 10 2019
accepted: 13 02 2020
pubmed: 25 5 2020
medline: 25 5 2020
entrez: 25 5 2020
Statut: ppublish

Résumé

We carried out an analysis of the total incidence of colon cancer throughout Kazakhstan. Retrospectively, according to the regional reports on endoscopic screening, the study showed an increase in the age-related incidence of colorectal cancer (CRC) cases from 2004-2008 to 2009-2014. The peak of morbidity in both periods was noted in the age category of >70 years. The indicators of the territorial distribution of CRC incidence make it possible to divide the regions into areas with low or high rates of CRC. Specific indicators showed newly diagnosed cases of CRC stages I, II, III, and IV in 2004-2018. The incidence rates of stages I and II showed a two-fold increase (35%-67.4%) and the incidence of stage IV showed a decline from 19.3% to 13.1% and of stage III from 45.7% to 19.5% from 2004 to 2018, respectively. An analysis of CRC incidence throughout Kazakhstan showed an increase in the overall incidence. Since population-based CRC screening was introduced in 2011, the morbidity was found to increase for stages I and II.

Identifiants

pubmed: 32447875
pii: ce.2019.198
doi: 10.5946/ce.2019.198
pmc: PMC7939768
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

32-37

Références

CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310

Auteurs

Alma Zhylkaidarova (A)

Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan.

Dilyara Kaidarova (D)

Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan.

Kanat Batyrbekov (K)

National Research Oncology Center, Nur-Sultan, Kazakhstan.

Oxana Shatkovskaya (O)

Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan.

Dinara Begimbetova (D)

Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.

Classifications MeSH